Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male wistar rats

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 5, 2009, Pages 933-938

  Gayathri, Renganathan ^a   Priya, D Kalpana Deepa ^a   Gunassekaran, GR ^a   Sakthisekaran, Dhanapal ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Glycoproteins; Lipid peroxidation; Mbrane atpases; Otein carbonyl; Smarinus officianalis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALKYLATING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; ANTINEOPLASTIC AGENT; DIETHYLNITROSAMINE; LIPID PEROXIDE; PHENOBARBITAL; SCAVENGER; TRITERPENE; URSOLIC ACID;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ERYTHROCYTE MEMBRANE; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ADENOSINE TRIPHOSPHATASES; ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; ERYTHROCYTE MEMBRANE; EXCITATORY AMINO ACID ANTAGONISTS; FREE RADICAL SCAVENGERS; LIPID PEROXIDES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; PHENOBARBITAL; RATS; RATS, WISTAR; TRITERPENES;

EID: 77952300961     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Ana I, Galan M, Munoz E, Jimenez R (1999). SAdenosylmethionine protects against cyclosporin A- induced alterations in rat liver plasma membrane fluidity and functions. J Pharmacol Exp Ther, 290, 774-81.
2. Berlett BS, Stadtman ER (1997). Protein oxidation in ageing, disease and oxidative stress. J Biol Chem, 272, 20313-6.
3. Berridge MJ, Lipp P, Bootman MD (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol, 1, 11-21.
4. Bhosale P, Motiwale L, Ignle AD, Gadre RV, Rao KVK 2002). Protective effect of Rhodotorula glutini - NCIM3353 on the development of hepatic preneoplastic lesions. Curr Sci, 83, 303-8.
5. Bonting SL (1970). In: Bittar EE, ed. Membranes and ion transport. London: Wiley Interscience, pp. 257-263.
6. Carafoli E (1994). Biogenesis: Plasma membrane calcium ATPase: 15 years of work on the purified enzyme. Faseb J, 8, 993-1002.
7. Chaterjee SN, Agarwal SN (1988). Liposomes as membrane model for study of lipid peroxidation. Free Radic Biol Med, 4, 51-72.
8. Contreras RG, Shoshani L, Flores-Maldonado CA, Lozaro A, Cereijido M (1999). Relationship between Na+K+ ATpase and cell attachment. J Cell Sci, 112, 4223-4232.
9. Crook M (1993). The determination of plasma or serum sialic acid. Clin Biochem, 26, 31-8.
10. Cunningham ML (1996). Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat Res, 365, 59-65.
11. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milazani A (2006). Biomarkers of oxidative stress in human disease. Clin Chem, 52, 601-23.
12. Dennis JW, Granovsky M, Warren CE (1999). Glycoprotein glycosylation and cancer progression. Biochem Biophys Acta, 473, 21-34.
13. Dich, J, Zahm SH, Hanberg A, Adami HO (1997). Pesticides and cancer. Cancer Causes Control, 8, 420-43.
14. Dodge JD, Mitchell G, Honatian DJ (1963). The preparation and chemical characteristics of hemoglobin free ghosts of human red blood cells. Arch Biochem Biophys, 180, 119-30.
15. Dragan YP, Hully JR, Nakamura J, et-al (1994). Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis, 15, 1451-8.
16. El-Serrag H (2004). Hepatocellular carcinoma: an epidemologic view. J Clin Gastroenterol, 35, 572-8.
17. Erbil K, Jones JD, Klee GG (1985). Use and limitations of serum total and Lipid-bound sialic acid concentrations as markers for colorectal cancer. Cancer, 55, 404-9.
18. Fiske CH, Subbarow Y (1925). The colorimetric determination of phosphorous. J Biol Chem, 66, 375-400.
19. Goldsworthy T, Hanigan M, Pitot H (1985). Models of hepatocarcinogenesis in the rat - contrasts and comparisions. CRC Crit Rev Toxicol, 7, 61-89.
20. Hjerten S, Pan H (1983). Purification and characterisation of two forms of a low affinity calcium ion ATPase from erythrocyte membrane. Biochem Biophys Acta, 28, 281-8.
21. Huber WW, Grasl-Kraupp B, NAME?, et-al 1997). TITLE? Arch Toxicol, 71, 575-81.
22. Jain KS, Sohet SB (1981). Calcium potentiates the peroxidation of erythrocyte membrane. Lipids, 642, 46-54.
23. Jewell SA, Bellomo G, Thor H, Orrenius S, Smith MT (1982). Bleb formation in thiol and calcium ion homeostasis. Science, 217, 1257-59.
24. Kang CB, Lee ES, Hur JH (1997). Effects of administration of CCl4 on liver function in rats. Kor J Vet Clin Med, 14, 273-278.
25. Kim JS, Huh JI, Song SH, et-al 1996).The antioxidative mechanism of ursolic acid. Kor J Gerontol, 6, 52-6.
26. Kokoglu E, Sonmez H, Uslu E, Uslu I (1992). Sialic acid levels in various types of cancer. Cancer Biochem Biophys, 13, 57-64.
27. Kunimoto M, Inoue K, Nojima S (1981). Effect of ferrous ion and ascorbate induced lipid peroxidation on liposomal membranes. Biophys Acta-Biomembranes, 646, 169-78.
28. Kurtul N, Cil MY, Bakan E (2004). The effects of alcohol and smoking on serum, saliva, and urine sialic acid levels. Saudi Med J, 25, 1839-44.
29. Lee IN, Chen CH, Sheu JC, et-al (2005). Identification of Human Hepatocellular carcinoma related Biomarkers by two dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res, 4, 2062-9.
30. Levine RL, Garland D, Oliver CN, et-al (1990). Determination of carbonyl content in oxidatively modifiedproteins. Methods Enzymol, 186, 464-478.
31. Li B, Cao CP, Mao GP (2005). Effect of proapoptosis protein on hepatocarcinogenis. Chin J Dig Dis, 6, 93-7.
32. Lindberg G, Rastam L, Gullberg B, Eklund GA, Tonberg S (1991). Serum sialic acid concentration and smoking: A population based study. BMJ, 303, 1306-7.
33. Lipskaia L, Lompre AM (2004). Alteration in temporal kinetics of Ca++ signalling and control of growth and proliferation. Biology Cell, 96, 55-68.
34. Lodato F, Mazzella G, Festi D, et-al (2006). Hepatocellular carcinoma Prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developed nations. World J Gastroenterol, 12, 7239-49.
35. Loppen S, Schneider D, Gaunitz F, et-al (2002). Title??? Cancer Res, 62, 5685-8.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin-phenol reagent. J Biol Chem, 193, 265-75.
37. Mandal TK, Chaterjee SN (1980). Ultraviolet and sunlight induced lipid peroxidation in liposomal membranes. Radiat Res, 83, 290-302.
38. Martin-Aragon S, De las heras B, Sanchez-Reus MI, Benedi J (2001). Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride induced liver damage in rats & primary cultures of rat hepatocytes. Exp Toxic Pathol, 53, 199-206.
39. Michejda CJ, Kroeger-Koepke MB, Koepke SR (1982). Nitrogen formation during in vivo and in vitro metabolism of N-Nitrosamines. In: Magee PN, ed. Nitrosamines and human cancer Banbury report, Cold Spring: Cold Spring harbor laboratory, 12, 69-81.
40. Moore M, Kitagawa T (1986). Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro. Int Rev Cytol, 101, 125-173.
41. Nakae D, Kobayashi Y, Akai H, Nabuaki A (1997). Involvement of 8- hydroxyguanine formation in the inhibition of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res, 57, 1281-1287.
42. Neibes D (1972). Determination of enzymic and degradation products of glycosaminoglycan metabolism in the serum of healthy and various subjects. Clin Chem Acta, 42, 399-408.
43. Ohinishi T, Suzuki T, Suzuki Y, Ozawa K (1982). A comparative study of plasma membrane magnesium ion ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta, 684, 64-74.
44. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipidperoxides in animal tissue by thiobarbituric acid reaction. Anal Biochem, 95, 351-358.
45. Parkin DM, Pisani P, Ferlay J (1999). Global cancer statistics. CA Cancer J Clin, 49, 33-64.
46. Pitot H (1986). Fundamentals of Oncology, 3rd edition. New york: Marcel Dekker.
47. Ponio M, Alho A, Heinala P, Nikkari ST, Sillanaukee P (1999). Serum and saliva levels of sialic acid are elevated in alcoholics. Alcohol Clin Exp Res, 23, 1060-64.
48. Qi Y, Chen X, Chan C-Y, et-al (2008). Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. Int J Cancer, 122, 2682-8.
49. Quist EE (1980). Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun, 92, 631-7.
50. Saravanan R, Viswanathan P, Pugalendi KV ( 2006). Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci, 78, 713-8.
51. Singer B, Greunberger D (1983). Alkylation of nucleic acids in vivo. In: Singer B and Grunberger D, eds. Molecular Biology of Mutagens and Carcinogens, New York: Plenum Press, 68-78.
52. Stadtman ER (1992). Protein oxidation and ageing. Science, 257, 1220-4.
53. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ (2000). Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res, 60, 2399-404.
54. Swenberg JA, Hoel DG, Magee PN (1991). Mechanistic and stastical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res, 51, 6409-14.
55. Tian Y, Lin G, Zheng R-X, et-al (2006). Anti hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Araliadecaisneana. World J Gastroenterol, 12, 874-9.
56. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem, 266, 37-56.
57. Verna L, Whysner J, Williams GM (1996). Nnitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther, 71, 57-81.
58. Wagner WD (1979). More sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem, 94, 394-7.
59. Warren L (1959). The thiobarbituric acid assay of sialic acid. J Biol Chem, 234, 1971-1975.